Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$129.69
-15.28-10.54%
al cierre: -
$127.00
-2.69-2.07%
After hour: Oct 10, 7:58 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
e.l.f. Beauty Inc ha un obiettivo di prezzo di consenso pari a $139, stabilito in base alle ultime valutazioni degli analisti di 16. Le ultime 3 valutazioni degli analisti sono state rilasciate da JP Morgan, UBS y Morgan Stanley il octubre 10, 2025, octubre 8, 2025 y octubre 8, 2025. Con un obiettivo di prezzo medio di $162.67 tra le JP Morgan, UBS y Morgan Stanley, c'è un implicito 28.08% upside per e.l.f. Beauty Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
JP Morgan
UBS
Morgan Stanley
Goldman Sachs
B of A Securities
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para e.l.f. Beauty
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/10/2025 | 32.28% | JP Morgan | $130 → $168 | Maintains | Overweight | |||
10/08/2025 | 18.11% | UBS | $112 → $150 | Maintains | Buy | |||
10/08/2025 | 33.86% | Morgan Stanley | $134 → $170 | Maintains | Overweight | |||
10/02/2025 | 22.05% | Goldman Sachs | $137 → $155 | Maintains | Buy | |||
09/17/2025 | 25.98% | B of A Securities | $135 → $160 | Maintains | Buy | |||
09/10/2025 | 25.98% | B. Riley Securities | $150 → $160 | Maintains | Buy | |||
09/08/2025 | 22.05% | Raymond James | $140 → $155 | Reiterates | Strong Buy → Strong Buy | |||
09/04/2025 | 18.11% | Piper Sandler | → $150 | Assumes | → Overweight | |||
09/02/2025 | 0.79% | Deutsche Bank | $121 → $128 | Downgrade | Buy → Hold | |||
08/11/2025 | 5.51% | Morgan Stanley | $114 → $134 | Upgrade | Equal-Weight → Overweight | |||
08/07/2025 | 0.79% | Canaccord Genuity | $150 → $128 | Maintains | Buy | |||
08/07/2025 | 2.36% | JP Morgan | $132 → $130 | Maintains | Overweight | |||
08/07/2025 | -11.81% | UBS | $120 → $112 | Maintains | Neutral | |||
08/07/2025 | 7.87% | Goldman Sachs | $120 → $137 | Maintains | Buy | |||
08/07/2025 | -10.24% | Morgan Stanley | $105 → $114 | Maintains | Equal-Weight | |||
07/25/2025 | 3.94% | JP Morgan | $123 → $132 | Maintains | Overweight | |||
07/17/2025 | -5.51% | UBS | $95 → $120 | Maintains | Neutral | |||
07/09/2025 | 18.11% | Canaccord Genuity | $114 → $150 | Maintains | Buy | |||
06/20/2025 | 6.3% | B of A Securities | $113 → $135 | Maintains | Buy | |||
06/13/2025 | 18.11% | B. Riley Securities | $110 → $150 | Maintains | Buy | |||
06/06/2025 | 2.36% | Truist Securities | $125 → $130 | Maintains | Buy | |||
06/06/2025 | 14.17% | Baird | $110 → $145 | Maintains | Outperform | |||
06/02/2025 | 2.36% | Raymond James | $105 → $130 | Maintains | Strong Buy | |||
05/30/2025 | -1.57% | Truist Securities | $75 → $125 | Maintains | Buy | |||
05/30/2025 | -3.15% | JP Morgan | $70 → $123 | Maintains | Overweight | |||
05/29/2025 | -11.02% | B of A Securities | $95 → $113 | Maintains | Buy | |||
05/29/2025 | -17.32% | Raymond James | $95 → $105 | Maintains | Strong Buy | |||
05/29/2025 | -14.17% | Piper Sandler | $81 → $109 | Maintains | Overweight | |||
05/29/2025 | -17.32% | Morgan Stanley | $70 → $105 | Maintains | Equal-Weight | |||
05/29/2025 | -9.45% | Jefferies | $75 → $115 | Maintains | Buy | |||
05/29/2025 | -10.24% | Canaccord Genuity | $105 → $114 | Maintains | Buy | |||
05/22/2025 | -25.2% | Raymond James | $85 → $95 | Maintains | Strong Buy | |||
05/21/2025 | -33.86% | UBS | $59 → $84 | Maintains | Neutral | |||
05/21/2025 | -25.2% | B of A Securities | $80 → $95 | Maintains | Buy | |||
05/14/2025 | -21.26% | Baird | $85 → $100 | Maintains | Outperform | |||
04/30/2025 | -36.22% | Piper Sandler | $90 → $81 | Maintains | Overweight | |||
04/24/2025 | -40.94% | Truist Securities | $100 → $75 | Maintains | Buy | |||
04/23/2025 | -40.94% | Jefferies | $175 → $75 | Maintains | Buy | |||
04/17/2025 | -53.54% | UBS | $74 → $59 | Maintains | Neutral | |||
04/17/2025 | -33.07% | Raymond James | $120 → $85 | Maintains | Strong Buy | |||
04/14/2025 | -33.07% | Baird | $110 → $85 | Maintains | Outperform | |||
04/11/2025 | -44.88% | JP Morgan | $127 → $70 | Maintains | Overweight | |||
03/31/2025 | -29.13% | Piper Sandler | $102 → $90 | Maintains | Overweight | |||
03/19/2025 | -40.94% | DA Davidson | $75 → $75 | Maintains | Neutral | |||
03/17/2025 | -40.94% | DA Davidson | $80 → $75 | Maintains | Neutral | |||
02/21/2025 | -2.36% | Goldman Sachs | $142 → $124 | Maintains | Buy | |||
02/18/2025 | -37.01% | DA Davidson | $80 → $80 | Maintains | Neutral | |||
02/07/2025 | -13.39% | Baird | $175 → $110 | Maintains | Outperform | |||
02/07/2025 | -13.39% | Jefferies | $175 → $110 | Maintains | Buy | |||
02/07/2025 | -17.32% | Canaccord Genuity | $174 → $105 | Maintains | Buy | |||
02/07/2025 | 11.81% | Goldman Sachs | $165 → $142 | Maintains | Buy | |||
02/07/2025 | -29.13% | B. Riley Securities | $150 → $90 | Reiterates | Buy → Buy | |||
02/07/2025 | -5.51% | Raymond James | $175 → $120 | Maintains | Strong Buy | |||
02/07/2025 | -33.07% | Stifel | $105 → $85 | Maintains | Hold | |||
02/07/2025 | -19.69% | Piper Sandler | $131 → $102 | Reiterates | Overweight → Overweight | |||
02/07/2025 | -37.01% | DA Davidson | $170 → $80 | Downgrade | Buy → Neutral | |||
02/07/2025 | -41.73% | UBS | $158 → $74 | Downgrade | Buy → Neutral | |||
02/07/2025 | -44.88% | Morgan Stanley | $153 → $70 | Downgrade | Overweight → Equal-Weight | |||
02/05/2025 | 3.15% | Piper Sandler | $167 → $131 | Maintains | Overweight | |||
02/05/2025 | 33.86% | DA Davidson | $170 → $170 | Maintains | Buy | |||
02/03/2025 | -17.32% | Stifel | $115 → $105 | Maintains | Hold | |||
01/31/2025 | 37.01% | Canaccord Genuity | $200 → $174 | Maintains | Buy | |||
01/21/2025 | 33.86% | DA Davidson | $170 → $170 | Maintains | Buy | |||
01/16/2025 | 24.41% | UBS | $156 → $158 | Maintains | Buy | |||
01/16/2025 | 28.35% | JP Morgan | $154 → $163 | Maintains | Overweight | |||
01/13/2025 | 20.47% | Morgan Stanley | $139 → $153 | Upgrade | Equal-Weight → Overweight | |||
01/06/2025 | 31.5% | Piper Sandler | $165 → $167 | Maintains | Overweight | |||
12/23/2024 | 33.86% | DA Davidson | $170 → $170 | Maintains | Buy | |||
12/19/2024 | 33.86% | DA Davidson | $170 → $170 | Maintains | Buy | |||
12/18/2024 | 18.11% | Truist Securities | $130 → $150 | Maintains | Buy | |||
12/13/2024 | 29.92% | Goldman Sachs | → $165 | Initiates | → Buy | |||
12/12/2024 | 4.72% | Deutsche Bank | → $133 | Initiates | → Hold | |||
12/11/2024 | 33.86% | DA Davidson | $170 → $170 | Maintains | Buy | |||
11/29/2024 | 33.86% | DA Davidson | $170 → $170 | Maintains | Buy | |||
11/25/2024 | 33.86% | DA Davidson | $170 → $170 | Maintains | Buy | |||
11/12/2024 | 33.86% | DA Davidson | $170 → $170 | Maintains | Buy | |||
11/07/2024 | -9.45% | Stifel | $131 → $115 | Maintains | Hold | |||
11/07/2024 | 18.11% | B. Riley Securities | $175 → $150 | Maintains | Buy | |||
11/07/2024 | 57.48% | Canaccord Genuity | $250 → $200 | Maintains | Buy | |||
11/07/2024 | 21.26% | JP Morgan | $167 → $154 | Maintains | Overweight | |||
11/07/2024 | 29.92% | Piper Sandler | $162 → $165 | Reiterates | Overweight → Overweight | |||
11/07/2024 | 33.86% | DA Davidson | $223 → $170 | Maintains | Buy | |||
10/30/2024 | 37.8% | Jefferies | $220 → $175 | Maintains | Buy | |||
10/29/2024 | 75.59% | DA Davidson | $223 → $223 | Maintains | Buy | |||
10/24/2024 | 3.15% | Stifel | $161 → $131 | Maintains | Hold | |||
10/21/2024 | 37.8% | Baird | $240 → $175 | Maintains | Outperform | |||
10/16/2024 | 2.36% | Truist Securities | $210 → $130 | Maintains | Buy | |||
10/15/2024 | 29.92% | B of A Securities | $190 → $165 | Maintains | Buy | |||
10/15/2024 | 75.59% | DA Davidson | $223 → $223 | Maintains | Buy | |||
10/11/2024 | 31.5% | JP Morgan | $207 → $167 | Maintains | Overweight | |||
10/07/2024 | 18.11% | UBS | $230 → $150 | Maintains | Buy | |||
10/01/2024 | 75.59% | DA Davidson | $223 → $223 | Maintains | Buy | |||
09/30/2024 | 9.45% | Morgan Stanley | $184 → $139 | Maintains | Equal-Weight | |||
09/18/2024 | 75.59% | DA Davidson | $223 → $223 | Maintains | Buy | |||
09/16/2024 | 27.56% | Piper Sandler | $260 → $162 | Maintains | Overweight | |||
09/12/2024 | 18.11% | TD Cowen | $235 → $150 | Maintains | Buy | |||
09/11/2024 | 75.59% | DA Davidson | $223 → $223 | Maintains | Buy | |||
09/10/2024 | 37.8% | B. Riley Securities | → $175 | Initiates | → Buy | |||
09/09/2024 | 49.61% | B of A Securities | $230 → $190 | Maintains | Buy | |||
09/03/2024 | 75.59% | DA Davidson | $223 → $223 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de e.l.f. Beauty (ELF)?
El último precio objetivo de e.l.f. Beauty (NYSE:ELF) fue comunicado por JP Morgan el octubre 10, 2025. La firma de analistas fijó un precio objetivo para $168.00 que espera ELF a rise dentro de 12 meses (un posible 32.28% upside). 89 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre e.l.f. Beauty (ELF)?
La última calificación de analistas para e.l.f. Beauty (NYSE:ELF) fue proporcionada por JP Morgan, y e.l.f. Beauty mantuvo su overweight calificación.
¿Cuándo se produjo la última revisión al alza de e.l.f. Beauty (ELF)?
La última revisión al alza de e.l.f. Beauty Inc se produjo en agosto 11, 2025, cuando Morgan Stanley elevó su precio objetivo a $134. Morgan Stanley anteriormente tenía an equal-weight para e.l.f. Beauty Inc.
¿Cuándo fue la última revisión a la baja de e.l.f. Beauty (ELF)?
La última revisión a la baja de e.l.f. Beauty Inc se produjo en septiembre 2, 2025, cuando Deutsche Bank cambió su precio objetivo de $121 a $128 para e.l.f. Beauty Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para e.l.f. Beauty (ELF)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de e.l.f. Beauty, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de e.l.f. Beauty se registró el octubre 10, 2025, por lo que la próxima calificación estará disponible en torno al octubre 10, 2026.
¿Es correcta la calificación de los analistas sobre e.l.f. Beauty (ELF)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de e.l.f. Beauty (ELF) fue un mantuvo con un precio objetivo de $130.00 a $168.00. El precio actual al que cotiza e.l.f. Beauty (ELF) es de $127.00, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.